Cannabidiolic Acid (CBD-a) Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 108 studies associated with Cannabidiolic Acid (CBD-a).
Here is a small sampling of Cannabidiolic Acid (CBD-a) studies by title:
- Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications
- Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
- Cannabidiolic Acid Rescues Deficits in Hippocampal Long-Term Potentiation in Models of Alzheimer's Disease: An Electrophysiological and Proteomic Analysis
- Rooted in therapeutics: comprehensive analyses of Cannabis sativa root extracts reveals potent antioxidant, anti-inflammatory, and bactericidal properties
- Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis
Components of the Cannabidiolic Acid (CBD-a) Research Dashboard
- Top medical conditions associated with Cannabidiolic Acid (CBD-a)
- Proven effects in clinical trials for Cannabidiolic Acid (CBD-a)
- Receptors associated with Cannabidiolic Acid (CBD-a)
- Individual study details for Cannabidiolic Acid (CBD-a)
Ready to become a subscriber? Go to our PRICING page.
Page Quick Links
Select New Cannabinoid
Overview - Cannabidiolic Acid (CBD-a)
Description of Cannabidiolic Acid (CBD-a)
The isolation and structure of cannabidiolic-acid (CBDA) was described by R. Mechoulam et al., in 1965.
The understanding of the pharmacodynamics and -kinetics of CBDA is more limited when compared to CBD.
Other Names:
Cannabidiolic AcidCannabidiolic acid, CBDA
IUPAC Name: 2,4-dihydroxy-3-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-pentylbenzoic acid
Molecular Formula: C22H30O4
Source–PubChem
Cannabidiolic Acid (CBD-a) Properties and Effects
Only Members can view Properties and Effects information. See DEMO page.
Cannabidiolic Acid (CBD-a) Receptor Binding
Only Members can view Receptor Binding information. See DEMO page.
Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You
should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a
medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
